RAO, Angela
 Distribuzione geografica
Continente #
NA - Nord America 517
EU - Europa 407
AS - Asia 137
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.064
Nazione #
US - Stati Uniti d'America 513
IE - Irlanda 118
SE - Svezia 80
CN - Cina 75
UA - Ucraina 73
SG - Singapore 53
DE - Germania 42
GB - Regno Unito 35
FI - Finlandia 20
CZ - Repubblica Ceca 14
BE - Belgio 5
RU - Federazione Russa 5
FR - Francia 4
IN - India 4
CA - Canada 3
NL - Olanda 3
IR - Iran 2
IT - Italia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
DK - Danimarca 1
EU - Europa 1
HR - Croazia 1
KG - Kirghizistan 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 1.064
Città #
Jacksonville 121
Dublin 118
Chandler 97
Nyköping 68
Singapore 44
Ashburn 36
Beijing 30
Dearborn 28
Cambridge 18
Medford 18
Princeton 18
Des Moines 15
Boardman 14
Brno 14
Ann Arbor 12
Lancaster 10
Los Angeles 10
Nanjing 6
Brussels 5
Hebei 5
Frankfurt am Main 4
Jinan 4
San Mateo 4
Shenyang 4
Zhengzhou 4
Edinburgh 3
Haikou 3
Munich 3
Ottawa 3
Taizhou 3
Wilmington 3
Ardabil 2
Bangalore 2
Helsinki 2
Leawood 2
Taiyuan 2
Tianjin 2
Tunis 2
Woodbridge 2
Amsterdam 1
Augusta 1
Bishkek 1
Bucharest 1
Changsha 1
Copenhagen 1
Cormeilles-en-Parisis 1
Hangzhou 1
Hanover 1
Ivry-sur-Seine 1
Kemerovo 1
Kyiv 1
Lisbon 1
Manchester 1
Messina 1
Mondeville 1
Mumbai 1
Nanchang 1
New York 1
Ningbo 1
Norwalk 1
Novokuznetsk 1
Panama City 1
Paris 1
Pune 1
Riva 1
Saint Louis 1
Saint Petersburg 1
Shanghai 1
Stockholm 1
Tirana 1
Vienna 1
Washington 1
Xiangfen 1
Zagreb 1
Ürümqi 1
Totale 777
Nome #
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 80
Anti-HIV agents: design and discovery of new potent RT inhibitors 76
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 71
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 69
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 65
Efficient 3D Database screening for novel HIV-1 IN inhibitors 63
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 62
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 62
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 61
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 58
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 58
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 58
Synthesis and structural features of new cyclofunctionalized benzimidazoles 54
Synthesis of new potential HIV-1 integrase inhibitors 54
Synthesis and antitumour activity of 1H,3H-thiazolo[3,4- a]benzimidazole derivatives 53
7-Chloro-1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole and 1-(2,6-difluorophenyl)-6-methyl-1H,3H- thiazolo[3,4-a]benzimidazole 49
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 46
Synthesis and anti-HIV activity of 1-(2,6-difluorophenyl)- 1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2- substituted benzimidazoles 42
Totale 1.081
Categoria #
all - tutte 4.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202069 0 0 0 0 0 0 0 21 2 28 18 0
2020/2021111 18 0 24 1 1 17 0 17 0 18 14 1
2021/2022120 5 35 2 3 8 0 11 3 0 1 15 37
2022/2023391 23 32 27 23 32 42 5 35 149 2 20 1
2023/202479 5 13 2 22 5 13 1 0 0 2 1 15
2024/202598 5 13 10 29 0 36 5 0 0 0 0 0
Totale 1.081